**Health Minister Defends Role of Treatment Abroad Amid Scrutiny Over Delays**
Health Minister Neophytos Charalambides addressed concerns regarding the role of overseas healthcare in Cyprus during an event focused on patients' rights and international treatment options. Charalambides emphasized that treatment abroad serves as a complement to the General Health System (Gesy) rather than a replacement, particularly for patients facing complex medical situations.
The minister acknowledged the limitations of Cyprus, a small island nation, in providing every specialized treatment domestically. He noted that certain rare diseases and advanced medical procedures are only available at select specialized centers outside the country. This reality necessitates the option for patients to seek treatment abroad, especially during challenging times when immediate care is critical.
Charalambides highlighted the importance of the national contact point, a resource designed to assist patients in navigating their options for overseas care. This initiative reflects the government's commitment to ensuring that patients and their families receive the support they need when considering treatment outside of Cyprus.
The Health Insurance Organization (HIO), which assumed responsibility for managing overseas treatment requests from the health ministry approximately eleven months ago, plays a crucial role in this process. Recent figures presented to the House health committee revealed that the HIO received 1,234 requests for international treatment over the past year. Of these requests, 889, or about 72 percent, were approved.
The discussion in the health committee, led by chairwoman and Disy MP Savia Orphanidou, was prompted by reports of delays in processing applications for treatment abroad. Among the approved requests, 657 patients have either traveled abroad or are currently receiving treatment overseas.
Monica Kyriakou, Director of the HIO, provided insights into the assessment process for applications, which are categorized based on urgency. Life-threatening cases are prioritized, requiring patients to depart for treatment within 48 hours. Urgent cases are processed within seven days, while regular cases are handled within a 30-day timeframe.
Kyriakou also clarified that the responsibility for submitting applications lies with Gesy doctors, who must accurately detail the seriousness of each case. She pointed out that a rejected application does not automatically disqualify a patient from receiving treatment abroad. In some instances, applications may be incorrectly completed by the referring doctor and can be resubmitted for consideration.
In response to ongoing concerns about the financial implications of seeking treatment abroad, a ministerial representative assured the committee that efforts are underway to facilitate the advance payment of travel and accommodation costs for individuals accompanying patients. Currently, this option is available only to vulnerable patients, but the government aims to expand this support to a broader range of cases.
The minister's remarks and the subsequent committee discussions underscore the government's recognition of the complexities surrounding overseas healthcare and the need for a robust support system for patients navigating these challenges. As the health system evolves, officials remain committed to addressing the concerns raised by patients and families, ensuring that they have access to necessary treatments regardless of geographical limitations.
The ongoing dialogue between health officials and stakeholders is expected to lead to improvements in the processing of overseas treatment applications, ultimately enhancing the overall experience for patients seeking care beyond Cyprus' borders.